These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22045968)

  • 21. A prospective natural-history study of coronary atherosclerosis.
    Stone GW; Maehara A; Lansky AJ; de Bruyne B; Cristea E; Mintz GS; Mehran R; McPherson J; Farhat N; Marso SP; Parise H; Templin B; White R; Zhang Z; Serruys PW;
    N Engl J Med; 2011 Jan; 364(3):226-35. PubMed ID: 21247313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
    Lansky AJ; Ng VG; Maehara A; Weisz G; Lerman A; Mintz GS; De Bruyne B; Farhat N; Niess G; Jankovic I; Lazar D; Xu K; Fahy M; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S62-72. PubMed ID: 22421232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and safety of pharmacological treatment versus percutaneous coronary angioplasty in patients with intermediate coronary artery lesions.
    Latacz P; Rostoff P; Gackowski A; El-Massri N; Konduracka E; Gajos G; Matysek J; Piwowarska W; Zmudka K
    Kardiol Pol; 2009 Aug; 67(8A):1004-12. PubMed ID: 19784905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.
    Nishigaki K; Yamazaki T; Kitabatake A; Yamaguchi T; Kanmatsuse K; Kodama I; Takekoshi N; Tomoike H; Hori M; Matsuzaki M; Takeshita A; Shimbo T; Fujiwara H;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):469-79. PubMed ID: 19463347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors and Outcomes of Routine Versus Optimal Medical Therapy in Stable Coronary Heart Disease.
    Chun S; Qiu F; Austin PC; Ko DT; Mamdani M; Wijeysundera DN; Czarnecki A; Bennell MC; Wijeysundera HC
    Am J Cardiol; 2015 Sep; 116(5):671-7. PubMed ID: 26119653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
    Morice MC; Feldman TE; Mack MJ; Ståhle E; Holmes DR; Colombo A; Morel MA; van den Brand M; Serruys PW; Mohr F; Carrié D; Fournial G; James S; Leadley K; Dawkins KD; Kappetein AP
    EuroIntervention; 2011 Oct; 7(6):670-9. PubMed ID: 21959312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
    J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and long term results of unprotected left main stenting using drug eluting stents.
    Tzifos V; Gatsis A; Gerasimou A; Chatzis D; Theodorakis G
    Cardiol J; 2011; 18(2):165-70. PubMed ID: 21432823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of chronic coronary disease: is the pendulum returning to equipoise?
    Boden WE
    Am J Cardiol; 2008 May; 101(10A):69D-74D. PubMed ID: 18474277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes.
    Lee SY; Mintz GS; Kim SY; Hong YJ; Kim SW; Okabe T; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    JACC Cardiovasc Interv; 2009 Jan; 2(1):65-72. PubMed ID: 19463400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified provisional stenting approach to coronary bifurcation lesions: clinical application of the "jailed-balloon technique".
    Singh J; Patel Y; Depta JP; Mathews SJ; Cyrus T; Zajarias A; Kurz HI; Lasala JM; Bach RG
    J Interv Cardiol; 2012 Jun; 25(3):289-96. PubMed ID: 22364484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of cardiovascular prognosis in patients receiving optimized secondary prevention measures after acute coronary syndrome.
    Lafitte M; Pucheu Y; Latry K; Dijos M; Casassus E; Couffinhal T
    Eur J Prev Cardiol; 2013 Apr; 20(2):283-90. PubMed ID: 22345674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.